Advertisement

Topics

ALTANA Pharma Inc Company Profile

17:59 EDT 20th September 2018 | BioPortfolio

ALTANA Pharma was launched in Canada in 1997 (as Byk Canada) with just three employees. Today we employ more than 200 people.Find out where it all began and read about where we are today. Learn about our medicines and therapeutic areas, our research and development activities, and finally, read about our unique corporate cultureAt ALTANA Pharma, we pride ourselves on our ability to maintain a casual environment that is highly collaborative and people-focused. We try to retain the best qualities of a small company environment even as the organization grows.
When it comes to employees' performance, we set high standards. But we are also interested in how results are achieved. Indeed, we are proud to say that our people-oriented approach to success has been used as a benchmark within the worldwide ALTANA Pharma AG group.
Our culture has been built on the foundation of key values:
Innovation. Integrity. Mutual Respect and Open Communication. Performance. Work-Life Balance.
These values guide us on how we choose to do business and our actions at every turn.
We are committed to the concept of work–life balance and are firm believers in "flex time" for staff. We also encourage staff participation in our Learning and Development programs and maintain an ongoing Rewards and Recognition program that allows colleagues to recognize their peers.
We constantly look for ways to do more. Our medical representatives are trained to provide service rather than simply sell drugs. We listen to our customers who tell us that ALTANA Pharma's responsiveness is one of the qualities that sets us apart from other drug companies.
For more information on ALTANA's competitive compensation and employee programs, please click here to be routed to the Careers Section.

Location

435 North Service Road West, 1st Floor
Oakville
Ontario
L6M 4X8
Canada

Contact

Phone: 905 469 9333
Fax: 905 469 4883
Email: webmaster@altanapharma.ca


News Articles [548 Associated News Articles listed on BioPortfolio]

What’s Next For Nycomed?

Following the acquisition of Altana in 2006, Nycomed grew from a small Scandinavian company into a global pharmaceutical company with the resources to perform its own R&D. Håkan Björklund, CEO, expl...

More pharma cos sign MoUs with MADC to set up bulk drugs park in MIHAN, Nagpur

Following execution of MoUs with pharma companies─ Centaur, SG Pharma, Arco Lifesciences, BDH Pharma, Maharashtra Airport Development Company Ltd (MADC) has recently inked MoUs with pharma companies

Deals this week: Zealand Pharma, Fulcrum Therapeutics, Forendo Pharma

Zealand Pharma has sold its future royalty streams and potential commercial milestones for Soliqua® 100/33/Suliqua® and Lyxumia®/Adlyxin® to Royalty Pharma...Read More... The post Deals this week:...

CR Pharma to Acquire Jiangzhong Pharma for $667 Million

China Resources Pharma will pay $667 million to acquire all the outstanding shares of Jiangzhong Pharma, a listed company. Three weeks ago, CR Pharma announced plans to acquire a stake in the parent c...

#jobs #lifescience Accountant – Biotech / Pharma (Up to $70K)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Accountant – Biotech / Pharma (Up to $70K) .MA-Boston, Publicly Traded ...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

Pharma Integrates 2017: A New Value Proposition for Pharma

London, UK, 22nd November 2017 / Sciad Newswire / Further insights from the podium as the Pharma Integrates panellists tackle changing product and technological developments and a new patient-payer ...

Tetra Bio-Pharma Inc.: Tetra Bio-Pharma Completes Acquisition of Remaining 20% Interest in PhytoPain Pharma Inc.

OTTAWA, ONTARIO -- (Marketwired) -- 03/19/18 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSX VENTURE: TBP)(OTCQB: TBPMF), today announced the completion of the previously announced acq...

Drugs and Medications [257 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [22 Associated PubMed Articles listed on BioPortfolio]

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Clinical trials go virtual, big pharma dives in.

21 Century Citizen Pharma: The FDA & Patient-Focused Product Development.

Perpetual debate regarding the delicate balance between access and innovation and the protection of the public health and safety dominate discussions of the United States Food and Drug Administration ...

A guide to manufacturing CAR T cell therapies.

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

The Common Pharmaceutical Market of the Eurasian Economic Union: A Regulatory Review.

According to the Treaty on the Eurasian Economic Union, a common pharmaceutical market was supposed to become operational on January 1, 2016. Nevertheless, the responsible parties did not meet the dea...

Clinical Trials [83 Associated Clinical Trials listed on BioPortfolio]

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

The primary objective is to determine clinical bioequivalence of Amphotericin B liposome for injection of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) liposome for injection of...

Companies [766 Associated Companies listed on BioPortfolio]

ALTANA

ALTANA AG is an international pharmaceuticals and chemicals group with sales of EUR948 million in the first quarter of 2006 and approx. 13,400 employees all over the world. With a return on sales (EBT...

ALTANA Pharma AG

ALTANA Pharma is a research-based company with dynamic growth. It employs over 8,800 people group-wide at locations in Europe, North and Latin America, South Africa, Asia and Australia. Research and p...

ALTANA Pharma Inc

ALTANA Pharma was launched in Canada in 1997 (as Byk Canada) with just three employees. Today we employ more than 200 people.Find out where it all began and read about where we are today. Learn about...

ALTANA Pharma Deutschland GmbH

ALTANA Pharma Deutschland ist ständig auf der Suche nach qualifizierten und motivierten Fachleuten aus dem medizinischen, naturwissenschaftlichen, technischen und betriebswirtschaftlichen Bereich, di...

ALTANA Inc

ALTANA Inc. is the parent corporation for four New York based divisions of ALTANA Pharma AG: E. Fougera & Company, Savage Laboratories, PharmaDerm and Pharmaderm Animal Health. ALTANA Pharma AG, an in...

More Information about "ALTANA Pharma Inc" on BioPortfolio

We have published hundreds of ALTANA Pharma Inc news stories on BioPortfolio along with dozens of ALTANA Pharma Inc Clinical Trials and PubMed Articles about ALTANA Pharma Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ALTANA Pharma Inc Companies in our database. You can also find out about relevant ALTANA Pharma Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record